SANOFI (1SAN.MI) Stock Fundamental Analysis
BIT:1SAN - FR0000120578 - Common Stock
79.44 EUR
+0.27 (+0.34%)
Overall 1SAN gets a fundamental rating of 6 out of 10. We evaluated 1SAN against 50 industry peers in the Pharmaceuticals industry. 1SAN scores excellent on profitability, but there are some minor concerns on its financial health. 1SAN is not valued too expensively and it also shows a decent growth rate. 1SAN also has an excellent dividend rating. This makes 1SAN very considerable for dividend investing!
1. Profitability
1.1 Basic Checks
1SAN had positive earnings in the past year.
In the past year 1SAN had a positive cash flow from operations.
In the past 5 years 1SAN has always been profitable.
In the past 5 years 1SAN always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of 1SAN (11.05%) is better than 80.00% of its industry peers.
The Return On Equity of 1SAN (19.73%) is better than 72.00% of its industry peers.
1SAN has a better Return On Invested Capital (13.84%) than 76.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for 1SAN is significantly below the industry average of 14.78%.
The last Return On Invested Capital (13.84%) for 1SAN is above the 3 year average (7.31%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.05% | ||
| ROE | 19.73% | ||
| ROIC | 13.84% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
1.3 Margins
1SAN has a better Profit Margin (20.35%) than 80.00% of its industry peers.
1SAN's Profit Margin has improved in the last couple of years.
1SAN's Operating Margin of 23.59% is fine compared to the rest of the industry. 1SAN outperforms 64.00% of its industry peers.
In the last couple of years the Operating Margin of 1SAN has grown nicely.
1SAN has a Gross Margin (71.70%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of 1SAN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.59% | ||
| PM (TTM) | 20.35% | ||
| GM | 71.7% |
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
1SAN has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
1SAN has about the same amout of shares outstanding than it did 1 year ago.
1SAN has about the same amout of shares outstanding than it did 5 years ago.
1SAN has a better debt/assets ratio than last year.
2.2 Solvency
The Debt to FCF ratio of 1SAN is 2.21, which is a good value as it means it would take 1SAN, 2.21 years of fcf income to pay off all of its debts.
1SAN's Debt to FCF ratio of 2.21 is amongst the best of the industry. 1SAN outperforms 84.00% of its industry peers.
A Debt/Equity ratio of 0.21 indicates that 1SAN is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.21, 1SAN is in the better half of the industry, outperforming 74.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 2.21 | ||
| Altman-Z | N/A |
ROIC/WACC1.86
WACC7.43%
2.3 Liquidity
1SAN has a Current Ratio of 1.27. This is a normal value and indicates that 1SAN is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of 1SAN (1.27) is comparable to the rest of the industry.
A Quick Ratio of 0.94 indicates that 1SAN may have some problems paying its short term obligations.
1SAN has a Quick ratio (0.94) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.94 |
3. Growth
3.1 Past
1SAN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.20%.
The Earnings Per Share has been growing slightly by 5.10% on average over the past years.
Looking at the last year, 1SAN shows a small growth in Revenue. The Revenue has grown by 6.45% in the last year.
The Revenue has been growing slightly by 3.31% on average over the past years.
EPS 1Y (TTM)-2.2%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%-8.09%
Revenue 1Y (TTM)6.45%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-6.99%
3.2 Future
Based on estimates for the next years, 1SAN will show a small growth in Earnings Per Share. The EPS will grow by 6.41% on average per year.
1SAN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.04% yearly.
EPS Next Y3.91%
EPS Next 2Y6.53%
EPS Next 3Y6.33%
EPS Next 5Y6.41%
Revenue Next Year0.18%
Revenue Next 2Y3.45%
Revenue Next 3Y4.32%
Revenue Next 5Y4.04%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 10.52, which indicates a very decent valuation of 1SAN.
Based on the Price/Earnings ratio, 1SAN is valued cheaply inside the industry as 84.00% of the companies are valued more expensively.
1SAN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.02.
A Price/Forward Earnings ratio of 9.11 indicates a reasonable valuation of 1SAN.
Based on the Price/Forward Earnings ratio, 1SAN is valued cheaply inside the industry as 82.00% of the companies are valued more expensively.
1SAN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.66.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.52 | ||
| Fwd PE | 9.11 |
4.2 Price Multiples
1SAN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. 1SAN is cheaper than 62.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, 1SAN is valued a bit cheaper than the industry average as 66.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.24 | ||
| EV/EBITDA | 10.24 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1SAN does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of 1SAN may justify a higher PE ratio.
PEG (NY)2.69
PEG (5Y)2.06
EPS Next 2Y6.53%
EPS Next 3Y6.33%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.96%, 1SAN is a good candidate for dividend investing.
1SAN's Dividend Yield is rather good when compared to the industry average which is at 3.06. 1SAN pays more dividend than 88.00% of the companies in the same industry.
1SAN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.45.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.96% |
5.2 History
The dividend of 1SAN has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
34.82% of the earnings are spent on dividend by 1SAN. This is a low number and sustainable payout ratio.
1SAN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP34.82%
EPS Next 2Y6.53%
EPS Next 3Y6.33%
BIT:1SAN (9/5/2025, 7:00:00 PM)
79.44
+0.27 (+0.34%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners40.34%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap193.75B
Analysts80
Price Target109.4 (37.71%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.96% |
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP34.82%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.86%
Min EPS beat(2)-2.29%
Max EPS beat(2)6.02%
EPS beat(4)2
Avg EPS beat(4)4.01%
Min EPS beat(4)-2.29%
Max EPS beat(4)14.5%
EPS beat(8)4
Avg EPS beat(8)2.17%
EPS beat(12)7
Avg EPS beat(12)2.71%
EPS beat(16)11
Avg EPS beat(16)3.44%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)1
Avg Revenue beat(4)-0.71%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)3.66%
Revenue beat(8)2
Avg Revenue beat(8)-1.12%
Revenue beat(12)5
Avg Revenue beat(12)9.77%
Revenue beat(16)9
Avg Revenue beat(16)21.47%
PT rev (1m)-2.68%
PT rev (3m)-9.8%
EPS NQ rev (1m)-2.88%
EPS NQ rev (3m)-10.87%
EPS NY rev (1m)-4.12%
EPS NY rev (3m)-4.12%
Revenue NQ rev (1m)-0.28%
Revenue NQ rev (3m)-6.9%
Revenue NY rev (1m)-0.82%
Revenue NY rev (3m)-1.33%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.52 | ||
| Fwd PE | 9.11 | ||
| P/S | 2.85 | ||
| P/FCF | 19.24 | ||
| P/OCF | 17.03 | ||
| P/B | 2.77 | ||
| P/tB | 20.85 | ||
| EV/EBITDA | 10.24 |
EPS(TTM)7.55
EY9.5%
EPS(NY)8.72
Fwd EY10.97%
FCF(TTM)4.13
FCFY5.2%
OCF(TTM)4.67
OCFY5.87%
SpS27.84
BVpS28.7
TBVpS3.81
PEG (NY)2.69
PEG (5Y)2.06
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.05% | ||
| ROE | 19.73% | ||
| ROCE | 16.7% | ||
| ROIC | 13.84% | ||
| ROICexc | 16.48% | ||
| ROICexgc | 66.95% | ||
| OM | 23.59% | ||
| PM (TTM) | 20.35% | ||
| GM | 71.7% | ||
| FCFM | 14.83% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
ROICexc(3y)8.13%
ROICexc(5y)7.97%
ROICexgc(3y)35.39%
ROICexgc(5y)35.54%
ROCE(3y)8.84%
ROCE(5y)8.55%
ROICexcg growth 3Y-13.63%
ROICexcg growth 5Y-1.43%
ROICexc growth 3Y-1.55%
ROICexc growth 5Y2.05%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
F-Score7
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 2.21 | ||
| Debt/EBITDA | 0.75 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 58.05% | ||
| Profit Quality | 72.91% | ||
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.94 | ||
| Altman-Z | N/A |
F-Score7
WACC7.43%
ROIC/WACC1.86
Cap/Depr(3y)73.02%
Cap/Depr(5y)67.36%
Cap/Sales(3y)6.35%
Cap/Sales(5y)5.97%
Profit Quality(3y)113.82%
Profit Quality(5y)104.22%
High Growth Momentum
Growth
EPS 1Y (TTM)-2.2%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%-8.09%
EPS Next Y3.91%
EPS Next 2Y6.53%
EPS Next 3Y6.33%
EPS Next 5Y6.41%
Revenue 1Y (TTM)6.45%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-6.99%
Revenue Next Year0.18%
Revenue Next 2Y3.45%
Revenue Next 3Y4.32%
Revenue Next 5Y4.04%
EBIT growth 1Y15.64%
EBIT growth 3Y1.33%
EBIT growth 5Y5.12%
EBIT Next Year34.08%
EBIT Next 3Y14.6%
EBIT Next 5Y9.88%
FCF growth 1Y24.23%
FCF growth 3Y-11.46%
FCF growth 5Y-0.14%
OCF growth 1Y10.87%
OCF growth 3Y-4.79%
OCF growth 5Y3.31%